"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(meh-JESS-trole ASS-uh-TATE)
Megace
Suspension
40 mg/mL
Tablets
20 mg
Tablets
40 mg
Apo-Megestrol
Linmegestrol
Megace OS
Nu-Megestrol
class: Progestin

 Actions Inhibits secretion of pituitary gonadotropins, thereby preventing follicular maturation and ovulation (contraceptive effect); inhibits spontaneous uterine contraction; transforms proliferative endometrium into secretory endometrium.

 Indications Palliative treatment of advanced inoperable, recurrent, or metastatic carcinoma of breast or endometrium.

Appetite stimulation in HIV-related cachexia.

 Contraindications Hypersensitivity to progestins; as diagnostic test for pregnancy.

 Route/Dosage

Breast Cancer

ADULTS: PO 40 mg qid.

Endometrial Cancer

ADULTS: PO 40 to 320 mg/day in divided doses.

Interactions None well documented.

Lab Test Interferences Endocrine, coagulation (increased amounts of coagulation factors), thyroid and LFT results may be affected by progestins; may alter metyrapone test results; may decrease glucose tolerance.

 Adverse Reactions

CARDIOVASCULAR: Hypertension; thromboembolic phenomena, including thrombophlebitis and pulmonary embolism. CNS: Insomnia; fatigue. DERMATOLOGIC: Rash; alopecia; mild acne. GI: Abdominal pain or discomfort; nausea; vomiting. GU: Breakthrough bleeding; change in menstrual flow; changes in cervical erosion and secretions; impotence. HEPATIC: Cholestatic jaundice. RESPIRATORY: Dyspnea. OTHER: Breast tenderness; masculinization of female fetus; edema; weight changes; decreased libido; tumor flare; carpal tunnel syndrome; increased appetite.

 Precautions

Pregnancy: Category D. Lactation: Excreted in breast milk. Children: Safety and efficacy not established. Fluid retention: Use with careful observation when conditions that might be affected by this factor are present (eg, asthma, cardiac or renal dysfunction, epilepsy). Hepatic impairment: Use with caution and with close monitoring in patients with liver dysfunction. Mental depression: Carefully observe patients with history of depression. Ophthalmic effects: Discontinue if there are any sudden changes in vision, sudden onset of proptosis, diplopia, migraine, papilledema, or retinal vascular lesions. Thromboembolic disease: Use with caution in patients with history of thromboembolic disease.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Store in dry, cool place at room temperature.

 Assessment/Interventions

  • Obtain complete patient history, including drug history and any known allergies. Note history of thromboembolic disease.
  • Assess results of baseline liver, thyroid, and coagulation tests prior to initiation of therapy and routinely during therapy.
  • Monitor blood glucose in patients with diabetes.
  • Monitor patient’s mental status: affect, mood, depression, behavioral changes.
  • Notify health care provider if any of these symptoms occur: pain in calves accompanied by swelling, warmth and redness; severe sudden headache; visual disturbances; numbness in extremities; signs of depression; signs of liver dysfunction (eg, dark urine, jaundice); breakthrough bleeding.

 Patient/Family Education

  • Caution patient that this medication must not be taken during pregnancy or when pregnancy is possible. Advise patient to use reliable form of birth control while taking this drug.
  • Explain potential significance of breakthrough bleeding, irregular menstrual cycles, and possible lack of menstrual cycle. Tell patient to notify health care provider of heavy or continuous menstrual flow.
  • Encourage patients with diabetes to monitor blood glucose more frequently until effect on diabetes control has been determined.
  • Instruct patient to report these symptoms to health care provider: pain in calves of legs with redness, warmth and swelling; sudden severe headache; visual disturbances; numbness in extremities; dyspnea; chest pain; edema; jaundice; dark urine; clay-colored stools.
  • Caution patient to avoid exposure to sunlight and other sources of ultraviolet light and to use sunscreen or wear protective clothing to avoid photosensitivity reaction.

Popularity: 2% [?]


If you're still unable to find appropriate information in the article, please use search form below